NEW DIRECTOR OF THE MOLECULAR MEDICINE PROGRAM

Matthew T. Rondina, MD, MS has accepted the position of Director of the Molecular Medicine Program (U2M2). Dr. Rondina is a natural fit to maintain the momentum of U2M2. He has a deep commitment to the program, strong relationships with the faculty and staff, extensive knowledge of the program’s administrative operations and broad clinical and…

Dr. Joseph Yost awarded an NIH R25 Grant

Dr. Joseph Yost has been awarded a five year NIH R25 grant entitled “Genomics Summer Research for Minorities: A Pathway to Promote Diversity in Science Research. This grant is to bring Underrepresented Minorities undergraduates (12 per year) into a program to give them exposure to Genomics and mentor them to apply to graduate or Medical…

NIH R01 awarded to Andrew Weyrich, PhD

Title:  Translational Control of Megakaryocyte and Platelet Function in Sepsis Project Period: 07/01/2018 – 06/30/2022 (4 Years) R01 HL142804 Megakaryocytes and platelets are critical effectors of acute and infectious inflammatory diseases such as sepsis. Results generated from this proposal will advance our understanding of how gene expression pathways in megakaryocytes (i.e., platelet precursors) and platelets…

Dr. Craig Selzman is the recipient of the Dr. Russell M. Nelson and Dantzel W. Nelson Presidential Endowed Chair

The University of Utah announced Friday, June 15th, that it has established the Dr. Russell M. Nelson and Dantzel W. Nelson Presidential Endowed Chair in Cardiothoracic Surgery and awarded its first recipient. The recipient of the endowed chair is Craig H. Selzman, a heart surgery professor in the University of Utah’s School of Medicine since…

Dr. J. David Symons awarded funding by the NIH/NHLBI

John David Symons R01HL141540 07/01/2018-05/31/2022 (4 years)   NIH/NHLBI Title: Autophagy maintains vascular function through a novel glycolysis-linked pathway regulating eNOS Aging is inevitable and is the primary risk factor for developing cardiovascular disease. The molecular mechanisms that drive vascular dysfunction in the context of aging are incompletely understood. Our overall hypothesis is that the…

Dr. Karla Pires selected for poster presentation at AHA Scientific Sessions 2018 in Chicago, IL.

Dr. Pires’ abstract entitled, PRDM16 is a Novel Regulator of Cardiac Hypertrophy, Remodeling and Mitochondrial Dynamics, was accepted for presentation at one of the American Heart Association’s Specialty Conferences in 2018 and is among the top 10 percent of the accepted abstracts presented at the conference. Because of her top-scoring abstract, she has been selected to re-present…